CEO Henrik Norström takes time out from his assignment – Christer Trägårdh becomes acting CEO

Report this content

This is an English translation of previously announced information on 23 December and 28 December, that was only published in Swedish.

Following the information published on Wednesday 23 December regarding Brighter’s CEO Henrik Norström being under investigation of the Swedish Economic Crime Authority for market abuse in the securities market, Henrik has decided to take a time out from his assignment as CEO. The decision has been made in consultation with the Board. Henrik denies the charges and is not detained.

Brighter’s new board member Christer Trägårdh, starting 1 January 2021, will assume the position as CEO until further notice. Emilie Erhardt Winiarski will remain acting Chairman of the Board.

“The Board respects Henrik's decision and Christer has both the experience and the competence to lead the company forward. Christer has worked very closely with the board and the company for a long time and have good relations with the management team. His focus will be on further accelerating the company's growth with a solid commercial focus,” says Emilie Erhardt Winiarski.

Henrik Norström will be at the company's disposal to support the management in its continued efforts.

The Board has initiated an internal investigation with the help of lawyer Olle Nykvist at Cirio Advokatbyrå and the company is cooperating with the authorities.

For further information, please contact:

Investor Relations
IR@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.

Documents & Links